Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY – Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately 351,637 shares traded hands during trading, an increase of 221% from the previous session’s volume of 109,583 shares.The stock last traded at $13.8120 and had previously closed at $13.85.
Wall Street Analysts Forecast Growth
Separately, Zacks Research cut shares of Sonic Healthcare from a “hold” rating to a “strong sell” rating in a research note on Wednesday, July 22nd. Two analysts have rated the stock with a Sell rating, According to MarketBeat, Sonic Healthcare currently has a consensus rating of “Sell”.
Read Our Latest Research Report on SKHHY
Sonic Healthcare Trading Up 1.5%
About Sonic Healthcare
Sonic Healthcare (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.
The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.
Read More
- Five stocks we like better than Sonic Healthcare
- MongoDB’s Spending Fears Collide With a Much Stronger Growth Story
- With the RSI at a Record Low, Is It Time to Go Bargain Hunting on Burlington?
- Could IonQ Become More Than a Quantum Computing Company?
- Why China’s Memory Chip Breakthrough Won’t Crash the Market
Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
